Compare MGYR & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGYR | HBIO |
|---|---|---|
| Founded | 1922 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.3M | 26.5M |
| IPO Year | 2021 | 2000 |
| Metric | MGYR | HBIO |
|---|---|---|
| Price | $19.28 | $7.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 1.5K | ★ 15.6K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.30% | N/A |
| EPS Growth | ★ 26.83 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | N/A | ★ $116,176,000.00 |
| Revenue This Year | N/A | $4.77 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | $13.19 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.03 | $0.38 |
| 52 Week High | $20.00 | $8.40 |
| Indicator | MGYR | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 51.90 | N/A |
| Support Level | $16.95 | N/A |
| Resistance Level | $19.89 | N/A |
| Average True Range (ATR) | 0.37 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 51.92 | 0.00 |
Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.